• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

守门人残基及其他:同源钙依赖性蛋白激酶作为兽医治疗顶复门寄生虫的药物开发靶点。

The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites.

作者信息

Keyloun Katelyn R, Reid Molly C, Choi Ryan, Song Yifan, Fox Anna M W, Hillesland Heidi K, Zhang Zhongsheng, Vidadala RamaSubbaRao, Merritt Ethan A, Lau Audrey O T, Maly Dustin J, Fan Erkang, Barrett Lynn K, Van Voorhis Wesley C, Ojo Kayode K

机构信息

Center for Emerging and Re-emerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Seattle, USA.

Department of Biochemistry, University of Washington, Seattle, Seattle, USA.

出版信息

Parasitology. 2014 Sep;141(11):1499-1509. doi: 10.1017/S0031182014000857. Epub 2014 Jun 13.

DOI:10.1017/S0031182014000857
PMID:24927073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4390295/
Abstract

Specific roles of individual CDPKs vary, but in general they mediate essential biological functions necessary for parasite survival. A comparative analysis of the structure-activity relationships (SAR) of Neospora caninum, Eimeria tenella and Babesia bovis calcium-dependent protein kinases (CDPKs) together with those of Plasmodium falciparum, Cryptosporidium parvum and Toxoplasma gondii was performed by screening against 333 bumped kinase inhibitors (BKIs). Structural modelling and experimental data revealed that residues other than the gatekeeper influence compound-protein interactions resulting in distinct sensitivity profiles. We subsequently defined potential amino-acid structural influences within the ATP-binding cavity for each orthologue necessary for consideration in the development of broad-spectrum apicomplexan CDPK inhibitors. Although the BKI library was developed for specific inhibition of glycine gatekeeper CDPKs combined with low inhibition of threonine gatekeeper human SRC kinase, some library compounds exhibit activity against serine- or threonine-containing CDPKs. Divergent BKI sensitivity of CDPK homologues could be explained on the basis of differences in the size and orientation of the hydrophobic pocket and specific variation at other amino-acid positions within the ATP-binding cavity. In particular, BbCDPK4 and PfCDPK1 are sensitive to a larger fraction of compounds than EtCDPK1 despite the presence of a threonine gatekeeper in all three CDPKs.

摘要

单个钙依赖蛋白激酶(CDPK)的具体作用各不相同,但总体而言,它们介导寄生虫生存所必需的基本生物学功能。通过针对333种碰撞激酶抑制剂(BKI)进行筛选,对犬新孢子虫、柔嫩艾美耳球虫和牛巴贝斯虫的钙依赖蛋白激酶(CDPK)与恶性疟原虫、微小隐孢子虫和刚地弓形虫的钙依赖蛋白激酶的构效关系(SAR)进行了比较分析。结构建模和实验数据表明,除了守门人残基外,其他残基也会影响化合物与蛋白质的相互作用,从而产生不同的敏感性谱。我们随后确定了每个直系同源物在ATP结合腔内潜在的氨基酸结构影响,这对于开发广谱顶复门CDPK抑制剂时需要考虑。尽管BKI文库是为特异性抑制甘氨酸守门人CDPKs而开发的,对苏氨酸守门人人类SRC激酶的抑制作用较低,但一些文库化合物对含丝氨酸或苏氨酸的CDPKs具有活性。CDPK同源物对BKI的不同敏感性可以基于疏水口袋的大小和方向差异以及ATP结合腔内其他氨基酸位置的特定变异来解释。特别是,尽管所有三种CDPKs都存在苏氨酸守门人,但BbCDPK4和PfCDPK1对更大比例的化合物敏感,而EtCDPK1则不然。

相似文献

1
The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites.守门人残基及其他:同源钙依赖性蛋白激酶作为兽医治疗顶复门寄生虫的药物开发靶点。
Parasitology. 2014 Sep;141(11):1499-1509. doi: 10.1017/S0031182014000857. Epub 2014 Jun 13.
2
Bumped kinase inhibitor prohibits egression in Babesia bovis.碰撞激酶抑制剂可阻止牛巴贝斯虫出芽。
Vet Parasitol. 2016 Jan 15;215:22-8. doi: 10.1016/j.vetpar.2015.10.023. Epub 2015 Nov 5.
3
In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.碰撞激酶抑制剂1294对相关形成囊肿的顶复门原虫刚地弓形虫和犬新孢子虫的体外及体内作用
Antimicrob Agents Chemother. 2015 Oct;59(10):6361-74. doi: 10.1128/AAC.01236-15. Epub 2015 Jul 27.
4
Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.两种新型钙依赖性蛋白激酶1抑制剂干扰感染犬新孢子虫速殖子的小鼠的垂直传播。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02324-16. Print 2017 Apr.
5
Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans.设计针对顶复门原虫中钙依赖性蛋白激酶的选择性抑制剂。
Trends Pharmacol Sci. 2015 Jul;36(7):452-60. doi: 10.1016/j.tips.2015.04.011. Epub 2015 May 20.
6
Reduced Activity of Mutant Calcium-Dependent Protein Kinase 1 Is Compensated in Plasmodium falciparum through the Action of Protein Kinase G.恶性疟原虫中突变型钙依赖性蛋白激酶1活性的降低通过蛋白激酶G的作用得到补偿。
mBio. 2016 Dec 6;7(6):e02011-16. doi: 10.1128/mBio.02011-16.
7
Roles of Apicomplexan protein kinases at each life cycle stage.顶复门蛋白激酶在每个生命周期阶段的作用。
Parasitol Int. 2012 Jun;61(2):224-34. doi: 10.1016/j.parint.2011.12.002. Epub 2011 Dec 24.
8
Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa.真核蛋白激酶在顶复门生物中的结构和进化分歧。
BMC Evol Biol. 2011 Nov 2;11:321. doi: 10.1186/1471-2148-11-321.
9
Molecular characterization and analysis of a novel calcium-dependent protein kinase from Eimeria tenella.柔嫩艾美耳球虫新型钙依赖蛋白激酶的分子特征与分析。
Parasitology. 2013 May;140(6):746-55. doi: 10.1017/S0031182012002107. Epub 2013 Feb 1.
10
Characterization of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) and its role in microneme secretion during erythrocyte invasion.恶性疟原虫钙依赖蛋白激酶 1(PfCDPK1)的特性及其在红细胞入侵期间微线体分泌中的作用。
J Biol Chem. 2013 Jan 18;288(3):1590-602. doi: 10.1074/jbc.M112.411934. Epub 2012 Nov 30.

引用本文的文献

1
Anti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1.隐孢子虫钙依赖性蛋白激酶1抑制剂BKI-1708的抗隐孢子虫功效
PLoS Negl Trop Dis. 2025 Jul 30;19(7):e0013263. doi: 10.1371/journal.pntd.0013263. eCollection 2025 Jul.
2
Bumped Kinase Inhibitors Inhibit both MAPKL1 and CDPK1.碰撞激酶抑制剂可同时抑制MAPKL1和CDPK1。
ACS Infect Dis. 2025 Jun 13;11(6):1552-1562. doi: 10.1021/acsinfecdis.5c00051. Epub 2025 May 23.
3
Versatile Imidazole Scaffold with Potent Activity against Multiple Apicomplexan Parasites.对多种顶复门寄生虫具有强效活性的多功能咪唑支架
ACS Infect Dis. 2025 Jun 13;11(6):1497-1507. doi: 10.1021/acsinfecdis.5c00049. Epub 2025 May 8.
4
Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in and HCT-8 Host Cells.在 和 HCT-8 宿主细胞中 5-酰胺基羧酰胺 bumped 激酶抑制剂 BKI-1748 的分子靶标。
Int J Mol Sci. 2024 Feb 26;25(5):2707. doi: 10.3390/ijms25052707.
5
Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in and .基于喹诺酮的 bumped kinase 抑制剂在 和 中的常见分子靶标
Int J Mol Sci. 2022 Feb 21;23(4):2381. doi: 10.3390/ijms23042381.
6
Drug Target Validation of the Protein Kinase Essential for Proliferation, Host Cell Invasion, and Intracellular Replication of the Human Pathogen Trypanosoma cruzi.蛋白激酶对增殖、宿主细胞侵袭和人体病原体克氏锥虫细胞内复制的必需性的药物靶标验证。
Microbiol Spectr. 2021 Oct 31;9(2):e0073821. doi: 10.1128/Spectrum.00738-21. Epub 2021 Sep 29.
7
Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivo.内啡肽样喹诺酮(ELQs)和 bumped 激酶抑制剂(BKIs):联合治疗对体外和体内新生隐球菌感染的协同和相加作用。
Int J Parasitol Drugs Drug Resist. 2021 Dec;17:92-106. doi: 10.1016/j.ijpddr.2021.08.007. Epub 2021 Aug 28.
8
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts.新型 bumped 激酶抑制剂 BKI-1748 在实验感染 Neospora caninum 速殖子和 Toxoplasma gondii 卵囊的非妊娠和妊娠小鼠中的体外活性、安全性和体内疗效。
Int J Parasitol Drugs Drug Resist. 2021 Aug;16:90-101. doi: 10.1016/j.ijpddr.2021.05.001. Epub 2021 May 18.
9
The Impact of BKI-1294 Therapy in Mice Infected With the Apicomplexan Parasite and Re-infected During Pregnancy.BKI-1294疗法对感染顶复门寄生虫并在孕期再次感染的小鼠的影响。
Front Vet Sci. 2020 Oct 15;7:587570. doi: 10.3389/fvets.2020.587570. eCollection 2020.
10
Reduced treatment frequencies with bumped kinase inhibitor 1369 are effective against porcine cystoisosporosis. bumped 激酶抑制剂 1369 减少治疗频率可有效对抗猪囊虫病。
Int J Parasitol Drugs Drug Resist. 2020 Dec;14:37-45. doi: 10.1016/j.ijpddr.2020.08.005. Epub 2020 Aug 21.

本文引用的文献

1
Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection.撞击激酶抑制剂1294可治疗已有的弓形虫感染。
Antimicrob Agents Chemother. 2014 Jun;58(6):3547-9. doi: 10.1128/AAC.01823-13. Epub 2014 Mar 31.
2
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes.开发强效且选择性的恶性疟原虫钙依赖性蛋白激酶4(PfCDPK4)抑制剂,以阻断疟疾向蚊子的传播。
Eur J Med Chem. 2014 Mar 3;74:562-73. doi: 10.1016/j.ejmech.2013.12.048. Epub 2014 Jan 11.
3
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation.PfCDPK4 的特异性抑制剂可阻断疟疾传播:化学生物学验证。
J Infect Dis. 2014 Jan 15;209(2):275-84. doi: 10.1093/infdis/jit522. Epub 2013 Oct 10.
4
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.一种新型钙依赖性蛋白激酶抑制剂作为治疗隐孢子虫病的先导化合物。
J Infect Dis. 2013 Oct 15;208(8):1342-8. doi: 10.1093/infdis/jit327. Epub 2013 Jul 21.
5
Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1.苯甲酰苯并咪唑类选择性抑制剂靶向隐孢子虫和刚地弓形虫钙依赖蛋白激酶-1。
Bioorg Med Chem Lett. 2012 Aug 15;22(16):5264-7. doi: 10.1016/j.bmcl.2012.06.050. Epub 2012 Jun 23.
6
Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors. bumped 激酶抑制剂阻断疟疾向蚊子的传播。
J Clin Invest. 2012 Jun;122(6):2301-5. doi: 10.1172/JCI61822. Epub 2012 May 8.
7
Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1.多种因素决定了锥虫钙依赖蛋白激酶 CDPK1 的选择性抑制。
J Med Chem. 2012 Mar 22;55(6):2803-10. doi: 10.1021/jm201725v. Epub 2012 Mar 13.
8
Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity.开发具有强效抗弓形虫活性的刚地弓形虫钙依赖蛋白激酶 1(TgCDPK1)抑制剂。
J Med Chem. 2012 Mar 8;55(5):2416-26. doi: 10.1021/jm201713h. Epub 2012 Feb 27.
9
Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii.疟原虫质体异戊烯前体合成与戊烷脒抗性的分子基础。
J Exp Med. 2011 Jul 4;208(7):1547-59. doi: 10.1084/jem.20110039. Epub 2011 Jun 20.
10
Structure determination of glycogen synthase kinase-3 from Leishmania major and comparative inhibitor structure-activity relationships with Trypanosoma brucei GSK-3.来自硕大利什曼原虫的糖原合酶激酶-3的结构测定以及与布氏锥虫GSK-3的比较性抑制剂构效关系
Mol Biochem Parasitol. 2011 Apr;176(2):98-108. doi: 10.1016/j.molbiopara.2010.12.009. Epub 2010 Dec 30.